BENDAMUSTINE HYDROCHLORIDE
NDC 10019-079, bendamustine hydrochloride, injection, from Baxter Healthcare Corporation.
- Product NDC
- 10019-079
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216078
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10019-079 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE100 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10019-079-01 | 10019007901 | 1 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/766b73e2-49bb-47f9-bbb1-44cfa1a3197eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10019-079
Use it
Look up 10019-079 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10019-079 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10019-079. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.